Lung Cancers Completed Phase 2 Trials for Sargramostim (DB00020)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung CancerTreatment
NCT00019331Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsTreatment
NCT00019084Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerTreatment
NCT00003269Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsSupportive Care
NCT00003125Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsTreatment
NCT00002475Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerTreatment